The relationship between structure and activity among opioid peptides
- 43 Downloads
Summary
Since the discovery and isolation of the endogenous opioid peptides Leu- and Met-enkephalin, structural studies have been focused on deducing the bioactive conformation of the peptide ligands. Theoretically, linear peptides can have many different backbone conformations, yet early, X-ray studies on enkephalin and its analogues showed only two different backbone conformations: extended and single β-bend. More recent reports include a third conformation for Leu-enkephalin and constrained opioid peptides from two ‘new’ classes (i.e. cyclic and ‘allaromatic’ peptides). In this report the relationship between solid-state X-ray structure and opioid peptide activity is examined. The N-terminal amine nitrogen and the two aromatic rings have previously been identified as structural features important to the biological activity of opioid peptides. From X-ray studies we find that the distances between the centroids of the aromatic rings, and between the N-terminal amine nitrogen and the centroid of the phenylalanine ring, vary over a large range. There is a discernible relationship, however, between the separation of the two rings and their orientation that correlates with activity.
Key words
enkephalin neuropeptide pharmacophore X-ray diffractionPreview
Unable to display preview. Download preview PDF.
References
- 1.Camerman, A. and Camerman, N., In Rapaka, R.S., Barnett, G., and Hawks, L. (Eds.) Opioid Peptides: Medicinal Chemistry, NIDA, Research Monograph, 69, NIDA, Rockville, MD, 1986, pp. 351–363.Google Scholar
- 2.Griffin, J. F. and Smith, G.D., In Rapaka, R.S., Barnett, G. and Hawks, L. (Eds.) Opioid Peptides: Medicinal Chemistry, NIDA Research Monograph 87, NIDA, Rockville, MD, 1988, pp. 41–59.Google Scholar
- 3.Deschamps, J.R., George, C., and Flippen-Anderson, J.L., Biopolymers, 40 (1996) 121.PubMedCrossRefGoogle Scholar
- 4.Walker, J.M., Bowen, W.D., Walker, F.O., Matsumoto, R.R., de Costa, B. and Rice, K.C., Biol. Funct., 42 (1990) 355.Google Scholar
- 5.Schiller, P.W., In Ellis, G.P. and West, G.B. (Eds.), Progress in Medicinal Chemistry, Vol. 28, Elsevier, Amsterdam, 1991, pp. 301–340.Google Scholar
- 6.For a review see: Hruby, V.J. and Gehrig, C.A., Med. Res. Rev., 9 (1989) 343.PubMedGoogle Scholar
- 7.Schiller, P.W., In Udenfriend, S. and Meihofer, J. (Eds.) The Peptides, Vol. 6. Academic Press, Orlando, FL, 1984, pp. 219–268.Google Scholar
- 8.Temussi, P.A., Picone, D., Castigilione-Morelli M.A. Motta, A. and Tancredi, T., Biopolymers, 28 (1989) 91.PubMedCrossRefGoogle Scholar
- 9.Rapaka, R.S., In Rapaka, R.S., Barnett, G. and Hawks, L. (Eds.) Opioid Peptides: Medicinal Chemistry, NIDA Research Monograph 69, NIDA, Rockville, MD, 1986, pp. 3–20.Google Scholar
- 10.Schwyzer, R., Biochemistry, 25 (1986) 6335.PubMedCrossRefGoogle Scholar
- 11.Hansen, P.E. and Morgan, B.A., In Udenfriend, S. and Meihofer, J. (Eds.) The Peptides, Vol. 6, Academic Press, Orlando, FL, 1984, pp. 269–321.Google Scholar
- 12.Aubry, A., Birlirakis, N., Sakarellos-Daitsiotis, M., Sakarellos, C. and Marraud, M., Biopolymers, 28 (1989) 27.PubMedCrossRefGoogle Scholar
- 13.Nikiforovich, G.V., Hruby, V.J., Prakash, O. and Gehrig, C.A., Biopolymers, 31 (1991) 941.PubMedCrossRefGoogle Scholar
- 14.Mosberg, H.I., Omnaas, J.R., Lomize, A., Heyl, D.L., Nordan, I., Mousigian, C., Davis, P. and Porreca, F., J. Med. Chem. 37 (1994) 4384.PubMedCrossRefGoogle Scholar
- 15.Sheldrick, G.M., SHELXTL/PC, v. 4.2, Siemens Analytical X-ray Instruments Inc., Madison, WI, U.S.A., 1991.Google Scholar
- 16.Karle, I.L., Karle, J., Mastropaolo, D., Camerman, A. and Camerman, N., Acta Crystallogr., B39 (1983) 625.Google Scholar
- 17.Griffin, J.F., Langs, D.A., Smith, G.D., Blundell, T.L., Tickle, I.J. and Bedarkar, S., Proc. Natl. Acad. Sci. USA, 83 (1986) 3272.PubMedCrossRefGoogle Scholar
- 18.Doi, M., Tanaka, M., Ishida, T., Inoue, M., Fujiware, T., Tomita, K., Kimura, T., Sakakibara, S. and Sheldrick, G.M., J. Biochem., 101 (1987) 485.PubMedGoogle Scholar
- 19.Smith, G.D. and Griffin, J.F., Science, 199 (1978) 1214.PubMedGoogle Scholar
- 20.Ishida, T., Kenmotsu, M., Mino, Y., Inoue, M., Fujiware, T., Tomita, K., Kimura, T. and Sakakibara, S., Biochem. J., 218 (1984) 677.PubMedGoogle Scholar
- 21.Stezowski, J.J., Eckle, E. and Bajusz, S., J. Chem. Soc. Chem. Commun. 1985 (1985) 681.CrossRefGoogle Scholar
- 22.Flippen-Anderson, J.L., Deschamps, J.R., Ward, K.B., George, C. and Houghten, R., Int. J. Pept. Res., 44 (1994) 97.CrossRefGoogle Scholar
- 23.Deschamps, J.R., George, C. and Flippen-Anderson, J.L., Acta Crystallogr., C52 (1996) 1583.Google Scholar
- 24.Fournie-Zaluski, M., Prange, T., Pascard C. and Roques, B.P., Biochem. Biophys. Res. Commun., 79 (1977) 1199.PubMedCrossRefGoogle Scholar
- 25.Flippen-Anderson, J.L., George, C., Deschamps, J.R., Reddy, P.A., Lewin, A.H. and Brine, G.A., Lett. Pept. Sci., 1 (1994) 107.CrossRefGoogle Scholar
- 26.Flippen-Anderson, J.L., Hruby, V.J., Collins, N., George, C. and Cudney, B., J. Am. Chem. Soc., 116 (1994) 7523CrossRefGoogle Scholar
- 27.Lomize, A.L., Flippen-Anderson, J.L., George, C. and Mosberg, H.I., J. Am. Chem. Soc., 116 (1994) 429.CrossRefGoogle Scholar
- 28.Collins, N., Flippen-Anderson, J.L., Haaseth, R., Deschamps, J.R., George, C., Kovar, K. and Hruby, V., J. Am. Chem. Soc. 118 (1996) 2143.CrossRefGoogle Scholar
- 29.Nikiforovich, G.V., Kover, K. E., Kolodziej, S.A., Nock, B., George, C., Flippen-Anderson, J.L. and Marshall, G. R., Abstracts, 14th American Peptide Symposium, Columbus, OH, U.S.A., 1995.Google Scholar
- 30.Flippen-Anderson, J.L., Deschamps, J.R., George, C., Reddy, P.A., Lewin, A.H., Brine, G.A., Sheldrick, G., and Nikiforovitch, G., J. Pept. Res., 49 (1997) 384.PubMedCrossRefGoogle Scholar
- 31.Ciajolo, M.R., Balboni, G., Picone, D., Salvadori, S., Tancredi, T., Temussi, P.A. and Tuzi, A., Int. J. Pept. Protein Res. 46 (1995) 134.PubMedCrossRefGoogle Scholar
- 32.Deschamps, J.R., Flippen-Anderson, J.L., Moore, C., Cudney, R. and George, C., Acta Crystallogr., C53 (1997) 1478.Google Scholar